Scientists have identified a promising blood protein marker that could help researchers detect chronic traumatic encephalopathy (CTE), a degenerative brain disease associated with repeated impacts to the head.
The findings come from two studies published in the medical journal . Researchers from Boston University, Banner Health and Washington University School of Medicine investigated whether specific forms of the tau protein could help identify advanced CTE.
Researchers Identify a Promising Blood Marker
The studies identified a protein marker called eMTBR-tau, which was found at higher levels in blood samples from former football players whose brain examinations later confirmed advanced CTE.
This protein is associated with abnormal tau deposits that can affect the normal functioning of nerve cells.
Study Examines Former Football Players
One study analysed blood samples from 21 former football players. Later brain examinations confirmed advanced CTE in 16 participants, early-stage CTE in two and no CTE in three.
Researchers observed substantially higher levels of the protein marker among participants with advanced disease.
Could This Change Future Diagnosis?
Until now, CTE could only be definitively confirmed through examination of brain tissue after death. A reliable blood-based marker could eventually help researchers study the disease during a person’s lifetime and support future clinical trials.
However, scientists have stressed that the test remains experimental. The studies involved relatively small groups, and the marker has not yet been validated for routine medical diagnosis.
Further research will be necessary before doctors can use this approach in everyday clinical practice.
